All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 565.88 Million TWD | -50.26% |
| 2022 | 1.13 Billion TWD | 91.39% |
| 2021 | 594.36 Million TWD | 59.71% |
| 2020 | 372.14 Million TWD | -5.38% |
| 2019 | 393.31 Million TWD | -49.22% |
| 2018 | 774.59 Million TWD | 3.07% |
| 2017 | 751.52 Million TWD | 14.66% |
| 2016 | 655.42 Million TWD | 5.22% |
| 2015 | 622.88 Million TWD | 9.6% |
| 2014 | 568.34 Million TWD | 29.23% |
| 2013 | 439.79 Million TWD | -10.53% |
| 2012 | 491.58 Million TWD | 22.38% |
| 2011 | 401.69 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 115.28 Million TWD | -13.46% |
| 2024 Q1 | 133.2 Million TWD | -4.36% |
| 2023 Q3 | 195.87 Million TWD | 108.93% |
| 2023 Q2 | 93.75 Million TWD | -38.16% |
| 2023 Q1 | 151.61 Million TWD | -40.53% |
| 2023 FY | 565.88 Million TWD | -50.26% |
| 2023 Q4 | 139.27 Million TWD | -28.9% |
| 2022 Q1 | 215.91 Million TWD | -1.66% |
| 2022 FY | 1.13 Billion TWD | 91.39% |
| 2022 Q4 | 254.92 Million TWD | -36.98% |
| 2022 Q2 | 262.23 Million TWD | 21.45% |
| 2022 Q3 | 404.49 Million TWD | 54.25% |
| 2021 Q3 | 154.17 Million TWD | 10.94% |
| 2021 Q4 | 219.57 Million TWD | 42.42% |
| 2021 FY | 594.36 Million TWD | 59.71% |
| 2021 Q2 | 138.96 Million TWD | 70.17% |
| 2021 Q1 | 81.66 Million TWD | -31.77% |
| 2020 Q3 | 106.88 Million TWD | -9.97% |
| 2020 Q4 | 119.68 Million TWD | 11.98% |
| 2020 Q1 | 26.87 Million TWD | -67.83% |
| 2020 FY | 372.14 Million TWD | -5.38% |
| 2020 Q2 | 118.71 Million TWD | 341.8% |
| 2019 Q3 | 91.85 Million TWD | -38.48% |
| 2019 Q4 | 83.51 Million TWD | -9.08% |
| 2019 FY | 393.31 Million TWD | -49.22% |
| 2019 Q1 | 68.62 Million TWD | -40.68% |
| 2019 Q2 | 149.31 Million TWD | 117.57% |
| 2018 Q2 | 234.07 Million TWD | 16.63% |
| 2018 FY | 774.59 Million TWD | 3.07% |
| 2018 Q4 | 115.69 Million TWD | -48.38% |
| 2018 Q3 | 224.13 Million TWD | -4.24% |
| 2018 Q1 | 200.68 Million TWD | 15.01% |
| 2017 Q3 | 219.07 Million TWD | 13.91% |
| 2017 Q2 | 192.33 Million TWD | 16.13% |
| 2017 Q1 | 165.61 Million TWD | 28.16% |
| 2017 FY | 751.52 Million TWD | 14.66% |
| 2017 Q4 | 174.49 Million TWD | -20.35% |
| 2016 Q2 | 197.15 Million TWD | 30.28% |
| 2016 Q3 | 177.7 Million TWD | -9.87% |
| 2016 Q4 | 129.22 Million TWD | -27.28% |
| 2016 Q1 | 151.33 Million TWD | -9.42% |
| 2016 FY | 655.42 Million TWD | 5.22% |
| 2015 FY | 622.88 Million TWD | 9.6% |
| 2015 Q2 | 183.05 Million TWD | 102.82% |
| 2015 Q4 | 167.07 Million TWD | -8.45% |
| 2015 Q3 | 182.49 Million TWD | -0.31% |
| 2015 Q1 | 90.25 Million TWD | 0.0% |
| 2014 FY | 568.34 Million TWD | 29.23% |
| 2013 FY | 439.79 Million TWD | -10.53% |
| 2013 Q1 | 106.82 Million TWD | -37.78% |
| 2012 FY | 491.58 Million TWD | 22.38% |
| 2012 Q4 | 171.69 Million TWD | 0.0% |
| 2011 FY | 401.69 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sinon Corporation | 5.19 Billion TWD | 89.117% |
| Taiwan Fertilizer Co., Ltd. | 4.05 Billion TWD | 86.032% |
| CH Biotech R&D Co., Ltd. | 1.26 Billion TWD | 55.092% |